Stable thyroid function during pregnancy linked to lower autism risk

A large study of over 51,000 pregnancies has found something reassuring: when mothers maintain normal thyroid hormone levels throughout pregnancy, their children's autism risk doesn't increase. The catch is the word "throughout" — it's the persistent imbalance that matters.

Thyroid hormones are crucial scaffolding for fetal brain development. The mother's thyroid essentially feeds the developing nervous system the chemical signals it needs to wire itself properly. When those signals stay disrupted across multiple trimesters, the research suggests, the risk of autism spectrum disorder rises. But here's what makes this study different from earlier work: mothers who had thyroid problems that were actively treated and brought under control didn't show increased risk. The problem wasn't the condition itself — it was letting it linger untreated.

What the data showed

Researchers at Ben-Gurion University in Israel analyzed births between 2011 and 2017, pulling records from a national health database. Among the 51,000 pregnancies tracked, about 4,400 mothers (8.6%) showed abnormal thyroid function at some point. The mothers with persistent imbalance — hormone disruption that continued across multiple trimesters — had measurably higher rates of children diagnosed with autism. The researchers also found a dose-response pattern: the more trimesters affected, the higher the risk climbed.

What matters most here is the distinction. "We found that while adequately treated chronic thyroid dysfunction was not associated with increased autism risk in offspring, ongoing imbalance across multiple trimesters was," said Idan Menashe, the study's lead researcher. In plain terms: having a thyroid condition isn't the risk. Having one that goes unmanaged is.

This reframes the conversation from "thyroid problems cause autism" to "unmanaged thyroid problems during pregnancy may increase autism risk." That's a meaningful difference, because it points to something actionable. Routine thyroid screening during pregnancy — already standard in many countries — combined with prompt adjustment of medication when levels drift, appears to be protective.

The finding underscores why prenatal care that includes thyroid monitoring matters, especially for women with known thyroid conditions or those at higher risk. It's not about preventing autism itself, which is a neurological variation shaped by multiple genetic and environmental factors. It's about supporting optimal fetal neurodevelopment during a critical window when the mother's hormones are doing much of the heavy lifting.

The next phase of this research will likely focus on which populations benefit most from early screening and how to ensure pregnant women with thyroid conditions get consistent monitoring and timely treatment adjustments throughout all nine months.